Vascugen Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Vascugen General Information

Description

Developer of regenerative medicine therapies designed to address degenerative vascular and ischemic disease conditions directly. The company's therapies utilize induced pluripotent stem cells and focus on advancing a pipeline of cell therapeutics to restore function to tissues where blood flow has been restricted, enabling physicians and medical researchers to develop therapeutic payloads in cardiovascular, solid tumor, and other indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5602 Research Park Boulevard
  • Suite 213
  • Madison, WI 53719
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 5602 Research Park Boulevard
  • Suite 213
  • Madison, WI 53719
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vascugen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 07-Sep-2023 Completed Pre-Clinical Trials
2. Seed Round 24-Aug-2020 Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Vascugen’s complete valuation and funding history, request access »

Vascugen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed A-2
Seed A-1
To view Vascugen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vascugen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of regenerative medicine therapies designed to address degenerative vascular and ischemic disease conditions d
Drug Discovery
Madison, WI
4 As of 2023

Cambridge, MA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vascugen Competitors (7)

One of Vascugen’s 7 competitors is BlueRock Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BlueRock Therapeutics Formerly VC-backed Cambridge, MA
Century Therapeutics Formerly VC-backed Philadelphia, PA
Sana Biotechnology Formerly VC-backed Seattle, WA
Celularity Formerly VC-backed Florham Park, NJ
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 7 competitors. Get the full list »

Vascugen Patents

Vascugen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023069480-A1 Hypoimmune vasculogenic cells Inactive 20-Oct-2021
US-20200281986-A1 Engineering mesodermal precursor cell compositions for the treatment or prophylaxis of perfusion disorders Inactive 07-Sep-2018

Vascugen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vascugen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cook Medical PE-Backed Company Minority
Angel (individual) Minority
IU Ventures Corporate Venture Capital Minority
Indiana University Limited Partner
To view Vascugen’s complete investors history, request access »

Vascugen FAQs

  • When was Vascugen founded?

    Vascugen was founded in 2017.

  • Where is Vascugen headquartered?

    Vascugen is headquartered in Madison, WI.

  • What is the size of Vascugen?

    Vascugen has 4 total employees.

  • What industry is Vascugen in?

    Vascugen’s primary industry is Drug Discovery.

  • Is Vascugen a private or public company?

    Vascugen is a Private company.

  • What is Vascugen’s current revenue?

    The current revenue for Vascugen is .

  • How much funding has Vascugen raised over time?

    Vascugen has raised $10.8M.

  • Who are Vascugen’s investors?

    Cook Medical, , IU Ventures, and Indiana University have invested in Vascugen.

  • Who are Vascugen’s competitors?

    BlueRock Therapeutics, Century Therapeutics, Sana Biotechnology, Celularity, and Fate Therapeutics are some of the 7 competitors of Vascugen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process